Immunotherapy Market By Type of Therapy (Monoclonal Antibodies, Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Transfer, Cytokines & Interleukins and Oncolytic Virus Therapy), By Application (Cancer, Autoimmune Disease, Infectious Diseases, Allergies, and Others), By Route of Administration (Intravenous, Subcutaneous, Intramuscular, Oral and Intratumoral), By End-user (Hospitals, Research Laboratories, Clinics, and Pharmaceutical Companies), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Type of Therapy

• Monoclonal Antibodies
• Checkpoint Inhibitors
• Cancer Vaccines
• Adoptive Cell Transfer
• Cytokines and Interleukins
• Oncolytic Virus Therapy

By Application

• Cancer
• Autoimmune Disease
• Infectious Diseases
• Allergies
• Others

By Route of Administration

• Intravenous
• Subcutaneous
• Intramuscular
• Oral
• Intratumoral

End-user  

• Hospitals
• Research Laboratories
• Clinics
• Pharmaceutical Companies

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Bristol-Myers Squibb (BMS)
• Merck & Co.
• Roche
• Amgen
• Novartis
• Gilead Sciences
• AstraZeneca
• Pfizer
• Eli Lilly
• Sanofi
• Johnson & Johnson
• Regeneron Pharmaceuticals
• Bayer
• Celgene (part of Bristol-Myers Squibb)
• Blueprint Medicines